logo
Trader Joe's recalls ‘Vampire Slayer' cheese curds in two states over listeria concerns

Trader Joe's recalls ‘Vampire Slayer' cheese curds in two states over listeria concerns

New York Post24-06-2025
A recall is underway for some Face Rock Creamery Vampire Slayer Cheese Curds sold at Trader Joe's grocery stores in two states.
Trader Joe's said Friday that a 'single lot code' of the cheese curds have been recalled in response to the potential risk of Listeria monocytogenes contamination.
The recalled product was offered at some Trader Joe's locations in Northern California as well as stores in the Nevada cities of Carson City, Reno and Sparks, according to a notice posted on the popular grocery store chain's website.
The stores in Northern California included those in Monterey, Fresno and 'all locations North,' Trader Joe's said.
The recalled cheese curds have a use-by date of '082925' on their container.
Face Rock Creamery said in a recall announcement published on the Food and Drug Administration's (FDA) website it recalled the affected product after 'a routine sampling program by the company' found it 'contained the bacteria.'
3 Trader Joe's said Friday that a 'single lot code' of the cheese curds have been recalled in response to the potential risk of Listeria.
Robert Miller
Healthy people that develop an infection after consuming food contaminated with listeria can experience fever, headaches, stiffness, nausea, abdominal pain and diarrhea. Such symptoms typically last one to three days.
However, in young children, elderly and those with compromised immune systems, it can bring on 'serious and sometimes fatal infections,' per the FDA.
Nobody had fallen ill due to the recalled cheese curds as of Friday, according to the FDA recall notice.
3 The recalled cheese curds have a use-by date of '082925' on their container.
FDA
'Face Rock Creamery is committed to ensuring the safety and quality of our products and is working closely with our distribution partners and regulatory agencies to resolve this matter swiftly and thoroughly,' the creamery said in the FDA recall announcement. 'We apologize for the inconvenience and appreciate the trust our customers place in us.'
Trader Joe's told customers in Northern California and Northern Nevada to either throw the recalled cheese curds in the trash or bring them back to their local store. If they return the product, they will get their money refunded.
Trader Joe's told FOX Business that 'nothing is more important than the health and safety of our customers and Crew Members.'
3 Nobody had fallen ill due to the recalled cheese curds as of Friday, according to the FDA recall notice.
FDA
The grocery store chain 'doesn't take any chances when it comes to product safety and quality' and will 'voluntarily take action quickly, aggressively investigating potential problems and removing the product from sale if there is any doubt about its safety or quality.'
The grocery store chain also said that it communicates about recalls via in-store signs, on its website and through emailed alerts.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Single Pass Inc. Launches Global Post-Market Evaluation of the Biopsy Tract Closure Device
Single Pass Inc. Launches Global Post-Market Evaluation of the Biopsy Tract Closure Device

Business Wire

time2 hours ago

  • Business Wire

Single Pass Inc. Launches Global Post-Market Evaluation of the Biopsy Tract Closure Device

LAKE FOREST, Calif.--(BUSINESS WIRE)--Single Pass Inc., a medical technology innovator focused on improving procedural safety in biopsy care, today announced the launch and first enrollment in B-S.A.F.E. (Biopsy with SinglePass: Assessing Fast & Effective Tract Closure) – a global, post-FDA market evaluation to generate real-world evidence of the SinglePass™ electrocautery biopsy closure device. I use SinglePass on every visceral biopsy for both tumor and parenchyma, including kidney and liver! This innovative device efficiently seals biopsy channels, reducing bleeding risks and improving patient safety across all my biopsy procedures. Share Despite the millions of solid organ percutaneous biopsies performed successfully each year, unintended bleeding post-procedure is a real risk requiring additional procedures, longer hospital stays, and increased costs. And in rare instances, the complications can be devastating. The SinglePass device is designed to cauterize the biopsy tract immediately after tissue extraction, offering a novel approach to reduce bleeding complications, enhance procedural efficiency, and optimize patient observation time. 'Single Pass's global post-market evaluation - B-S.A.F.E. - reflects our commitment to innovation backed by evidence,' said John Zehren, CEO of Single Pass Inc. 'We're honored to work alongside frontline clinicians to validate real-world safety, usability, and performance, bringing an innovative solution for patients undergoing biopsy procedures.' B-S.A.F.E. is a multicenter post-market device evaluation that will assess reduction in post-biopsy bleeding and complications, post-biopsy observation time and workflow optimization. 'The SinglePass device represents a transformational advancement in the world of core needle biopsy,' said Dr. Alexander Misono, MD, MBA, RPVI, Chief of Interventional Radiology at Hoag Hospital Irvine in Irvine, CA. 'With the ability of SinglePass to provide immediate and reliable tract closure, we are already witnessing an inevitable shift in the way we manage bleeding risk and patient recovery. I'm proud to contribute to this evaluation and help drive the future standard of care.' "I use SinglePass on every visceral biopsy for both tumor and parenchyma, including kidney and liver!' remarked Dr. Francis Kang, Clinical Chief of Interventional Radiology at Robert Wood Johnson University Hospital in New Brunswick, NJ. 'This innovative device efficiently seals biopsy channels, significantly reducing bleeding risks and improving patient safety across all my biopsy procedures." For more information, visit About Single Pass Inc. Single Pass Inc. is a privately held medical device company dedicated to enhancing safety and workflow efficiency in image-guided biopsy procedures. Its flagship device, the SinglePass Electrocautery Biopsy Closure Device, enables clinicians to cauterize the biopsy tract in a single step, potentially improving patient outcomes and reducing procedural complexity. The company is headquartered in Lake Forest, California.

Blueberry Recall Update as FDA Issues Most Severe Risk Level
Blueberry Recall Update as FDA Issues Most Severe Risk Level

Newsweek

time3 hours ago

  • Newsweek

Blueberry Recall Update as FDA Issues Most Severe Risk Level

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A recall of hundreds of boxes of blueberries due to possible contamination with Listeria monocytogenes has now been issued the highest risk warning by the U.S. Food and Drug Administration (FDA). Alma Pak International LLC, based in Georgia, issued a voluntary recall for 400 boxes of its organic blueberries on June 9. The FDA subsequently issued its Class 1 risk classification on July 1. Newsweek contacted Alma Pak International LLC for comment by email outside of regular working hours. Stock image. Alma Pak International LLC issued a voluntary recall for 400 boxes of its organic blueberries on June 9. Stock image. Alma Pak International LLC issued a voluntary recall for 400 boxes of its organic blueberries on June 9. Sina Schuldt/picture-alliance/dpa/AP Images Why It Matters A Class I risk classification represents "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death," according to the FDA. Listeria infection, or listeriosis, may lead to a range of symptoms in infected individuals. For those experiencing less severe infections, symptoms include fever, muscle aches, nausea, vomiting and diarrhea, which often last between one and three days, the FDA said. For more severe and potentially life-threatening infections, symptoms may include headaches, stiff neck, confusion, loss of balance and convulsions. Severe infections are particularly dangerous for newborns, adults over age 65 and those with weakened immune systems. What To Know A total of 400 boxes of the firm's organic blueberries are impacted by the recall. Each box weighs 30 lbs. The blueberries were shipped to one customer in North Carolina, and can be identified by the Lot numbers: 13325 G1060 / 13325 G 1096. The recall was initiated after the firm obtained positive test results for Listeria monocytogenes during routine testing of the product. What People Are Saying Haley F. Oliver, a professor of food science at Purdue University, told Newsweek previously: "Listeria monocytogenes is a common microorganism that can be found in the natural environment, for example in soil. There are many factors that determine if someone gets listeriosis — a listeria infection. In most instances, an immunocompromised person, so young, old, pregnant or otherwise immunocompromised, must eat contaminated food. The number of bacteria resulting in infection and the amount of time before illness varies considerably. Symptoms vary among people but can include fever, flu-like symptoms, headache, stiff neck, confusion and loss of balance." Mary O'Riordan, a professor of microbiology and immunology at the University of Michigan Medical School, told Newsweek previously: "Listeria has an unusual capacity to grow at refrigerated temperatures. Although the bacterium can contaminate many types of food, cheeses or deli meats that are kept in cold storage for long periods in stores or at home, are a place where listeria can keep growing. "Early symptoms of listeria infection look similar to other common foodborne infections, including fever, diarrhea and vomiting, so it's often not diagnosed right away. Unfortunately, sometimes listeria can spread into the brain and cause more serious illness, like meningitis. In those cases, if people experience headache, stiff neck or confusion, they should seek urgent medical attention." The FDA said on its website: "Pregnant women and their unborn or newborn baby, adults over the age of 65, and those with weakened immune systems, are all considered to be high-risk groups that are susceptible to the serious and adverse effects of listeriosis." What Happens Next The recall is listed as ongoing, according to the FDA. The agency advises anyone who suspects that they have developed symptoms resembling a listeriosis infection to contact their healthcare provider immediately.

FDA Recalls 3 Oranges To Prove They Can Juggle
FDA Recalls 3 Oranges To Prove They Can Juggle

The Onion

time3 hours ago

  • The Onion

FDA Recalls 3 Oranges To Prove They Can Juggle

SILVER SPRING, MD—Issuing a public warning for Americans to watch or they might miss out, the U.S. Food and Drug Administration reportedly recalled three navel oranges Wednesday to prove that they could juggle. 'Toss 'em here,' said spokesperson John Lavietes, adding that American consumers who had recently purchased navel, Valencia, or blood oranges should not consume the citrus fruits but instead bring three of them to the nearest FDA office so the federal agency could show them something. 'It's been a while, but we can definitely do it. Organic, GMO, even a mandarin or tangelo should be brought to this lectern immediately. Come on, any region or distributor works. They have to be firm, though. If they're not firm, we can't do it.' At press time, the FDA had recalled one more orange to replace the one that had rolled under the table.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store